
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $773K | $3.9M | $14.7M | $8.9M | $9.5M | |
Revenue Growth (YoY) | -47.7% | 404.01% | 277.39% | -39.16% | 6.19% | |
Cost of Revenues | $385K | $1.4M | $728K | $671K | $334K | |
Gross Profit | $388K | $2.5M | $14M | $8.3M | $9.2M | |
Gross Profit Margin | 50.19% | 63.4% | 95.05% | 92.5% | 96.48% | |
R&D Expenses | $12.3M | $33.9M | $14M | $15.7M | $12.5M | |
Selling, General & Admin | $15.6M | $18.2M | $22.5M | $17.3M | $18.2M | |
Other Inc / (Exp) | $3.5M | $5.9M | -$4.1M | -$178K | $1.2M | |
Operating Expenses | $26.8M | $51.7M | $36.5M | $33M | $30.6M | |
Operating Income | -$26.4M | -$49.2M | -$22.5M | -$24.7M | -$21.5M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$21.9M | -$43.3M | -$25.8M | -$23.3M | -$18.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$1.2M | -- | $541K | -$1.8M | -- | |
Net Income to Company | -$20.7M | -$43.3M | -$26.4M | -$21.5M | -$18.6M | |
Minority Interest in Earnings | $36K | $251K | $80K | -$7K | -$27K | |
Net Income to Common Excl Extra Items | -$20.6M | -$43M | -$26.3M | -$21.5M | -$18.6M | |
Basic EPS (Cont. Ops) | -$0.14 | -$0.26 | -$0.15 | -$0.12 | -$0.09 | |
Diluted EPS (Cont. Ops) | -$0.14 | -$0.26 | -$0.15 | -$0.12 | -$0.09 | |
Weighted Average Basic Share | $150M | $164.5M | $169.8M | $172.7M | $200.2M | |
Weighted Average Diluted Share | $150M | $164.5M | $169.8M | $172.7M | $200.2M | |
EBITDA | -$24.4M | -$48.3M | -$21.8M | -$24M | -$20.9M | |
EBIT | -$26.4M | -$49.2M | -$22.5M | -$24.7M | -$21.5M | |
Revenue (Reported) | $773K | $3.9M | $14.7M | $8.9M | $9.5M | |
Operating Income (Reported) | -$26.4M | -$49.2M | -$22.5M | -$24.7M | -$21.5M | |
Operating Income (Adjusted) | -$26.4M | -$49.2M | -$22.5M | -$24.7M | -$21.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $293K | $5.2M | $2.4M | $1.4M | $1.5M | |
Revenue Growth (YoY) | 76.51% | 1687.37% | -54.44% | -39.48% | 4.02% | |
Cost of Revenues | $112K | $176K | $119K | $98K | $36K | |
Gross Profit | $181K | $5.1M | $2.3M | $1.3M | $1.5M | |
Gross Profit Margin | 61.78% | 96.64% | 95.01% | 93.21% | 97.6% | |
R&D Expenses | $3.4M | $3M | $4.2M | $3M | $3.1M | |
Selling, General & Admin | $3.9M | $8.5M | $4.7M | $5M | $4.9M | |
Other Inc / (Exp) | $5.6M | -$698K | $25K | -$359K | $1.9M | |
Operating Expenses | $7.2M | $11.5M | $8.9M | $8M | $8M | |
Operating Income | -$7.1M | -$6.4M | -$6.6M | -$6.7M | -$6.5M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$1.4M | -$7.1M | -$6.2M | -$6.6M | -$4.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -$1.8M | -- | -- | |
Net Income to Company | -$1.4M | -$7.1M | -$4.4M | -$6.6M | -$4.1M | |
Minority Interest in Earnings | $32K | $6K | $32K | $16K | $4K | |
Net Income to Common Excl Extra Items | -$1.4M | -$7.1M | -$4.4M | -$6.5M | -$4.1M | |
Basic EPS (Cont. Ops) | -$0.01 | -$0.04 | -$0.03 | -$0.04 | -$0.02 | |
Diluted EPS (Cont. Ops) | -$0.01 | -$0.04 | -$0.03 | -$0.04 | -$0.02 | |
Weighted Average Basic Share | $158.7M | $169.6M | $170.1M | $182.9M | $226.1M | |
Weighted Average Diluted Share | $158.7M | $169.6M | $170.1M | $182.9M | $226.1M | |
EBITDA | -$6.8M | -$6.2M | -$6.5M | -$6.5M | -$6.3M | |
EBIT | -$7.1M | -$6.4M | -$6.6M | -$6.7M | -$6.5M | |
Revenue (Reported) | $293K | $5.2M | $2.4M | $1.4M | $1.5M | |
Operating Income (Reported) | -$7.1M | -$6.4M | -$6.6M | -$6.7M | -$6.5M | |
Operating Income (Adjusted) | -$7.1M | -$6.4M | -$6.6M | -$6.7M | -$6.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $900K | $8.8M | $11.9M | $8M | $9.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $403K | $1.5M | $671K | $650K | $272K | |
Gross Profit | $497K | $7.4M | $11.2M | $7.4M | $9.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $12.4M | $33.5M | $15.2M | $14.5M | $12.6M | |
Selling, General & Admin | $15M | $22.7M | $18.8M | $17.6M | $18M | |
Other Inc / (Exp) | $10.5M | -$358K | -$3.4M | -$562K | $3.4M | |
Operating Expenses | $26.6M | $55.9M | $33.9M | $32.1M | $30.6M | |
Operating Income | -$26.1M | -$48.6M | -$22.8M | -$24.8M | -$21.3M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$14.9M | -$48.9M | -$24.9M | -$23.6M | -$16.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$1.2M | -- | -$1.3M | -- | -- | |
Net Income to Company | -$13.7M | -$48.9M | -$23.7M | -$23.6M | -$16.2M | |
Minority Interest in Earnings | $39K | $225K | $106K | -$23K | -$39K | |
Net Income to Common Excl Extra Items | -$13.7M | -$48.7M | -$23.6M | -$23.7M | -$16.2M | |
Basic EPS (Cont. Ops) | -$0.09 | -$0.29 | -$0.14 | -$0.13 | -$0.08 | |
Diluted EPS (Cont. Ops) | -$0.09 | -$0.29 | -$0.14 | -$0.13 | -$0.08 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$24.4M | -$47.8M | -$22M | -$24.1M | -$20.7M | |
EBIT | -$26.1M | -$48.6M | -$22.8M | -$24.8M | -$21.3M | |
Revenue (Reported) | $900K | $8.8M | $11.9M | $8M | $9.6M | |
Operating Income (Reported) | -$26.1M | -$48.6M | -$22.8M | -$24.8M | -$21.3M | |
Operating Income (Adjusted) | -$26.1M | -$48.6M | -$22.8M | -$24.8M | -$21.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $293K | $5.2M | $2.4M | $1.4M | $1.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $112K | $176K | $119K | $98K | $36K | |
Gross Profit | $181K | $5.1M | $2.3M | $1.3M | $1.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $3.4M | $3M | $4.2M | $3M | $3.1M | |
Selling, General & Admin | $3.9M | $8.5M | $4.7M | $5M | $4.9M | |
Other Inc / (Exp) | $5.6M | -$698K | $25K | -$359K | $1.9M | |
Operating Expenses | $7.2M | $11.5M | $8.9M | $8M | $8M | |
Operating Income | -$7.1M | -$6.4M | -$6.6M | -$6.7M | -$6.5M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$1.4M | -$7.1M | -$6.2M | -$6.6M | -$4.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -$1.8M | -- | -- | |
Net Income to Company | -$1.4M | -$7.1M | -$4.4M | -$6.6M | -$4.1M | |
Minority Interest in Earnings | $32K | $6K | $32K | $16K | $4K | |
Net Income to Common Excl Extra Items | -$1.4M | -$7.1M | -$4.4M | -$6.5M | -$4.1M | |
Basic EPS (Cont. Ops) | -$0.01 | -$0.04 | -$0.03 | -$0.04 | -$0.02 | |
Diluted EPS (Cont. Ops) | -$0.01 | -$0.04 | -$0.03 | -$0.04 | -$0.02 | |
Weighted Average Basic Share | $158.7M | $169.6M | $170.1M | $182.9M | $226.1M | |
Weighted Average Diluted Share | $158.7M | $169.6M | $170.1M | $182.9M | $226.1M | |
EBITDA | -$6.8M | -$6.2M | -$6.5M | -$6.5M | -$6.3M | |
EBIT | -$7.1M | -$6.4M | -$6.6M | -$6.7M | -$6.5M | |
Revenue (Reported) | $293K | $5.2M | $2.4M | $1.4M | $1.5M | |
Operating Income (Reported) | -$7.1M | -$6.4M | -$6.6M | -$6.7M | -$6.5M | |
Operating Income (Adjusted) | -$7.1M | -$6.4M | -$6.6M | -$6.7M | -$6.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $32.6M | $55.7M | $11.4M | $35.4M | $45.8M | |
Short Term Investments | $9M | $2.6M | $46.5M | $50K | $2M | |
Accounts Receivable, Net | $4K | $50.8M | $297K | $745K | $638K | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $2.4M | $2.4M | $1.8M | $2.2M | $2.6M | |
Total Current Assets | $44M | $111.5M | $60M | $38.4M | $51M | |
Property Plant And Equipment | $5.6M | $4.9M | $5.7M | $4.8M | $4.4M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $10.7M | $10.7M | $10.7M | $10.7M | $10.7M | |
Other Intangibles | $47M | $46.8M | $46.7M | $46.6M | $46.5M | |
Other Long-Term Assets | $616K | $630K | $627K | $577K | $614K | |
Total Assets | $107.9M | $174.5M | $123.7M | $101M | $113.2M | |
Accounts Payable | $2.6M | $3.5M | $2.4M | $2.1M | $1.2M | |
Accrued Expenses | $1.7M | $22.1M | $3.8M | $1.1M | $1.2M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $762K | $831K | $952K | $882K | $1.2M | |
Other Current Liabilities | $10K | $375K | -- | -- | -- | |
Total Current Liabilities | $7.8M | $47.1M | $19M | $18M | $14M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $12.8M | $83.6M | $51.7M | $39M | $36.2M | |
Common Stock | $393.9M | $434.5M | $440.3M | $451.3M | $484.7M | |
Other Common Equity Adj | -$3.7M | -$5.2M | -$3.6M | -$3.1M | -$2.9M | |
Common Equity | $96.2M | $92.2M | $73.3M | $63.4M | $78.4M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -$1.1M | -$1.3M | -$1.4M | -$1.4M | -$1.4M | |
Total Equity | $95.1M | $90.9M | $71.9M | $62M | $77M | |
Total Liabilities and Equity | $107.9M | $174.5M | $123.7M | $101M | $113.2M | |
Cash and Short Terms | $41.6M | $58.4M | $57.9M | $35.5M | $47.8M | |
Total Debt | $523K | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $56.2M | $78.1M | $15.5M | $43.6M | $47.9M | |
Short Term Investments | $6.2M | $1.9M | $31.4M | $45K | $19K | |
Accounts Receivable, Net | $109K | $515K | $203K | $77K | $213K | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $2.1M | $1.4M | $2.6M | $2M | $1.9M | |
Total Current Assets | $64.6M | $81.9M | $49.7M | $45.7M | $50M | |
Property Plant And Equipment | $5.1M | $4.5M | $5.6M | $5M | $4.1M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $10.7M | $10.7M | $10.7M | $10.7M | $10.7M | |
Other Intangibles | $46.9M | $46.8M | $46.7M | $46.5M | $46.5M | |
Other Long-Term Assets | $601K | $639K | $635K | $596K | $504K | |
Total Assets | $127.9M | $144.5M | $113.2M | $108.5M | $111.8M | |
Accounts Payable | $2.8M | $3M | $3M | $2.2M | $2M | |
Accrued Expenses | $988K | $4.3M | $404K | $991K | $902K | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $786K | $750K | $963K | $1.1M | $1.2M | |
Other Current Liabilities | $180K | $79K | $38K | -- | -- | |
Total Current Liabilities | $6.6M | $24.6M | $17.2M | $16.9M | $13.1M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $11.4M | $59.3M | $44.2M | $37.5M | $34.1M | |
Common Stock | $415.3M | $435.8M | $441.3M | $466.6M | $489.3M | |
Other Common Equity Adj | -$2.1M | -$5.1M | -$3.1M | -$2.8M | -$2.7M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -$1.1M | -$1.3M | -$1.4M | -$1.4M | -$1.4M | |
Total Equity | $116.6M | $85.2M | $69M | $71M | $77.7M | |
Total Liabilities and Equity | $127.9M | $144.5M | $113.2M | $108.5M | $111.8M | |
Cash and Short Terms | $62.4M | $79.9M | $46.8M | $43.6M | $47.9M | |
Total Debt | $523K | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$20.7M | -$43.3M | -$26.4M | -$21.5M | -$18.6M | |
Depreciation & Amoritzation | $2M | $873K | $727K | $692K | $609K | |
Stock-Based Compensation | $2.2M | $3.5M | $4.3M | $4.6M | $5.1M | |
Change in Accounts Receivable | -$714K | -$857K | $50.3M | -$446K | $106K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$19.8M | -$23.6M | $1.1M | -$28.6M | -$23.1M | |
Capital Expenditures | $64K | $340K | $413K | $674K | $565K | |
Cash Acquisitions | $13.1M | $10.1M | -- | -- | -- | |
Cash From Investing | $13M | $9.7M | -$46.2M | $46.4M | -$2.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $25.1M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$26K | -$20K | -$32K | -$54K | -$54K | |
Repurchase of Common Stock | -$27K | -$54K | -$17K | -$37K | -$23K | |
Other Financing Activities | -$356K | -$1.1M | -$106K | -- | -$171K | |
Cash From Financing | $29.9M | $36.9M | $1.6M | $6.4M | $35.9M | |
Beginning Cash (CF) | $10.1M | $33.2M | $56.3M | $11.9M | $36M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $23.2M | $23.1M | -$43.5M | $24.3M | $10.5M | |
Ending Cash (CF) | $33.2M | $56.3M | $11.9M | $36M | $46.4M | |
Levered Free Cash Flow | -$19.8M | -$23.9M | $646K | -$29.2M | -$23.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$1.4M | -$7.1M | -$4.4M | -$6.6M | -$4.1M | |
Depreciation & Amoritzation | $286K | $178K | $171K | $175K | $164K | |
Stock-Based Compensation | $539K | $1.1M | $1M | $1.2M | $1.2M | |
Change in Accounts Receivable | -$135K | $50.3M | $95K | $668K | $424K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$7.4M | $21.9M | -$11.2M | -$5.8M | -$4.9M | |
Capital Expenditures | $11K | $46K | $188K | $38K | $97K | |
Cash Acquisitions | $10.1M | -- | -- | -- | -- | |
Cash From Investing | $10.1M | -$46K | $15.4M | -$38K | $1.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$8K | -$13K | -$13K | -$14K | |
Repurchase of Common Stock | -$13K | -$8K | -$37K | -$23K | -$15K | |
Other Financing Activities | -$614K | -- | -- | -- | -$224K | |
Cash From Financing | $21M | $513K | $1K | $14M | $5M | |
Beginning Cash (CF) | $33.2M | $56.3M | $11.9M | $36M | $46.4M | |
Foreign Exchange Rate Adjustment | -$80K | -$42K | -$100K | -$70K | -$73K | |
Additions / Reductions | $23.6M | $22.4M | $4.2M | $8.2M | $2.1M | |
Ending Cash (CF) | $56.7M | $78.6M | $16M | $44.1M | $48.3M | |
Levered Free Cash Flow | -$7.4M | $21.9M | -$11.4M | -$5.8M | -$5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$13.7M | -$48.9M | -$23.7M | -$23.6M | -$16.2M | |
Depreciation & Amoritzation | $1.6M | $765K | $720K | $696K | $598K | |
Stock-Based Compensation | $2.1M | $4.1M | $4.2M | $4.8M | $5.1M | |
Change in Accounts Receivable | -$497K | $49.6M | $88K | $127K | -$138K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$22.2M | $5.8M | -$32.1M | -$23.1M | -$22.2M | |
Capital Expenditures | $65K | $375K | $555K | $524K | $624K | |
Cash Acquisitions | $17.9M | -- | -- | -- | -- | |
Cash From Investing | $17.9M | -$375K | -$30.7M | $31M | -$367K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$18K | -$28K | -$37K | -$54K | -$55K | |
Repurchase of Common Stock | -$38K | -$49K | -$46K | -$23K | -$15K | |
Other Financing Activities | -- | -- | -- | -- | -$395K | |
Cash From Financing | $50.8M | $16.5M | $1.1M | $20.4M | $26.9M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $46.5M | $21.9M | -$61.7M | $28.3M | $4.3M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$22.2M | $5.4M | -$32.6M | -$23.6M | -$22.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$1.4M | -$7.1M | -$4.4M | -$6.6M | -$4.1M | |
Depreciation & Amoritzation | $286K | $178K | $171K | $175K | $164K | |
Stock-Based Compensation | $539K | $1.1M | $1M | $1.2M | $1.2M | |
Change in Accounts Receivable | -$135K | $50.3M | $95K | $668K | $424K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$7.4M | $21.9M | -$11.2M | -$5.8M | -$4.9M | |
Capital Expenditures | $11K | $46K | $188K | $38K | $97K | |
Cash Acquisitions | $10.1M | -- | -- | -- | -- | |
Cash From Investing | $10.1M | -$46K | $15.4M | -$38K | $1.9M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$8K | -$13K | -$13K | -$14K | |
Repurchase of Common Stock | -$13K | -$8K | -$37K | -$23K | -$15K | |
Other Financing Activities | -$614K | -- | -- | -- | -$224K | |
Cash From Financing | $21M | $513K | $1K | $14M | $5M | |
Beginning Cash (CF) | $33.2M | $56.3M | $11.9M | $36M | $46.4M | |
Foreign Exchange Rate Adjustment | -$80K | -$42K | -$100K | -$70K | -$73K | |
Additions / Reductions | $23.6M | $22.4M | $4.2M | $8.2M | $2.1M | |
Ending Cash (CF) | $56.7M | $78.6M | $16M | $44.1M | $48.3M | |
Levered Free Cash Flow | -$7.4M | $21.9M | -$11.4M | -$5.8M | -$5M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.